Established in 1990, this Indian manufacturer employs approximately 3,065 individuals and specializes in developing and manufacturing IP-led niche finished dosage formulations. As a CTD dossier owner and manufacturer, it holds GMP certifications from major regulatory authorities, including the US FDA, EU-GMP, Health Canada, and UK MHRA, ensuring compliance with stringent international quality standards. The company operates eight manufacturing units across India, Singapore, Italy, the United States, and Kenya, producing a range of products, including soft gelatin capsules, tablets, and ointments. As a CTD dossier owner and manufacturer, its products are distributed in over 100 countries worldwide.

Established in 1990, this Indian manufacturer employs approximately 3,065 individuals and specializes in developing and manufacturing IP-led niche finished dosage formulations. As a CTD dossier owner and manufacturer, it holds GMP certifications from major regulatory authorities, including the US FDA, EU-GMP, Health Canada, and UK MHRA, ensuring compliance with stringent international quality standards. The company operates eight manufacturing units across India, Singapore, Italy, the United States, and Kenya, producing a range of products, including soft gelatin capsules, tablets, and ointments. As a CTD dossier owner and manufacturer, its products are distributed in over 100 countries worldwide.

This company is a manufacturer and exporter of pharmaceutical products with over two decades of experience. They operate across three manufacturing facilities in India, specializing in a wide range of dosage forms including tablets, capsules, liquids, injectables, topicals, and nasal sprays. Their product portfolio encompasses generic, branded, nutraceutical, over-the-counter (OTC), and herbal medicines. Key therapy areas are not explicitly mentioned. They adhere to stringent quality standards with ISO 9001:2008 certification. The company exports its products to numerous regions globally, including the EU, North America, Africa, and the Middle East.